Equifax
EFX
142.43
-0.05
-0.04%
Equifax
US · EFX
#1080 by market cap
Listed 1970
142.43
-0.05
-0.04%
Live - 5344 symbols - heartbeat 57s ago
· 2026-10-08 06:18
Pre-market
149.99
+5.31%
After-hours
142.43
0.00%
- Market cap
- 16.73B
- P/E (TTM)i
- 25.03
- P/Bi
- 3.82
- EPSi
- 5.32
- Div yieldi
- 1.49%
- 52W posi
- 5%
Reader sentiment
Are you bullish or bearish on EFX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.89, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.92% YoY
Margins
- Gross margin
- 56.45%
- Operating margin
- 18.03%
- Net margin
- 10.87%
Key ratios & quality
- Enterprise valuei
- 21.65B
- Altman Z-Scorei
- 2.89
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.41B | 3.51B | 4.13B | 4.92B | 5.12B | 5.27B | 5.68B | 6.07B |
| Gross profit | 1.97B | 1.99B | 2.39B | 2.94B | 2.95B | 2.93B | 3.16B | 3.43B |
| Selling & admin expenses | 1.21B | 1.99B | 1.32B | 1.32B | 1.33B | 1.39B | 1.45B | 1.61B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 448.00M | -335.40M | 676.60M | 1.14B | 1.06B | 933.60M | 1.04B | 1.10B |
| Pretax profit | 370.40M | -413.80M | 685.20M | 949.20M | 929.70M | 717.90M | 810.50M | 894.90M |
| Tax | 53.40M | -35.70M | 159.00M | 200.70M | 229.50M | 166.20M | 203.20M | 230.60M |
| Net profit | 317.00M | -378.10M | 526.20M | 748.50M | 700.20M | 551.70M | 607.30M | 664.30M |
| Basic EPS | 3 | -3 | 4 | 6 | 6 | 4 | 5 | 5 |
| Diluted EPS | 2.56 | -3.18 | 4.24 | 6.02 | 5.65 | 4.40 | 4.84 | 5.32 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.44B | 1.54B | 1.54B | 1.55B | 1.65B | 1.70B |
| Gross profit | 785.30M | 872.40M | 881.70M | 889.40M | 881.80M | 926.40M |
| Selling & admin expenses | 374.90M | 384.20M | 434.10M | 421.00M | 411.00M | 422.50M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 235.80M | 310.80M | 264.30M | 284.20M | 287.70M | 314.20M |
| Pretax profit | 185.40M | 261.30M | 215.30M | 232.90M | 235.80M | 256.90M |
| Tax | 51.60M | 68.70M | 53.80M | 56.50M | 62.50M | 71.80M |
| Net profit | 133.80M | 192.60M | 161.50M | 176.40M | 173.30M | 185.10M |
| Basic EPS | 1 | 2 | 1 | 1 | 1 | 2 |
| Diluted EPS | 1.06 | 1.53 | 1.29 | 1.44 | 1.42 | 1.54 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 902.30M | 1.21B | 2.48B | 1.12B | 1.37B | 1.36B | 1.36B | 1.41B |
| Cash & ST investments | 223.60M | 401.30M | 1.68B | 224.70M | 285.20M | 216.80M | 169.90M | 180.80M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 7.15B | 7.91B | 9.61B | 11.04B | 11.55B | 12.28B | 11.76B | 11.86B |
| Total current liabilities | 826.80M | 1.36B | 2.48B | 2.29B | 2.02B | 2.02B | 1.81B | 2.34B |
| Short-term debt | 4.90M | 3.10M | 1.10B | 824.80M | 967.20M | 963.40M | 687.70M | 1.04B |
| Long-term debt | 2.63B | 3.38B | 3.28B | 4.47B | 4.82B | 4.75B | 4.32B | 4.06B |
| Total liabilities | 3,997,500,000.00 | 5,286,100,000.00 | 6,401,500,000.00 | 7,439,700,000.00 | 7,574,600,000.00 | 7,592,500,000.00 | 6,839,800,000.00 | 7,126,000,000.00 |
| Total equity | 3.16B | 2.62B | 3.21B | 3.60B | 3.97B | 4.69B | 4.92B | 4.74B |
| Retained earnings | 4.72B | 3.85B | 4.19B | 4.75B | 5.26B | 5.61B | 6.02B | 6.45B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.48B | 1.50B | 1.46B | 1.41B | 1.49B | 1.58B |
| Cash & ST investments | 195.20M | 189.00M | 189.00M | 180.80M | 183.40M | 170.10M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 11.85B | 11.92B | 11.83B | 11.86B | 11.94B | 11.98B |
| Total current liabilities | 1.73B | 1.95B | 1.98B | 2.34B | 2.45B | 2.63B |
| Short-term debt | 639.70M | 847.00M | 759.30M | 1.04B | 1.25B | 1.41B |
| Long-term debt | 4.32B | 4.05B | 4.05B | 4.06B | 4.06B | 4.06B |
| Total liabilities | 6,742,300,000.00 | 6,682,100,000.00 | 6,756,000,000.00 | 7,126,000,000.00 | 7,259,200,000.00 | 7,461,900,000.00 |
| Total equity | 5.11B | 5.24B | 5.08B | 4.74B | 4.68B | 4.52B |
| Retained earnings | 6.10B | 6.23B | 6.33B | 6.45B | 6.55B | 6.67B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 672.20M | 313.80M | 946.20M | 1.33B | 757.10M | 1.12B | 1.32B | 1.62B |
| Depreciation & amortization | 315.90M | 337.30M | 399.30M | 489.60M | 568.60M | 619.80M | 680.60M | 726.90M |
| Free cash flow | 350.30M | -85.80M | 524.90M | 865.80M | 132.60M | 515.50M | 813.00M | 1.13B |
| Dividends paid | -187.90M | -188.70M | -189.50M | -190.00M | -191.10M | -191.80M | -193.20M | -232.80M |
| Stock buybacks / issuance | -- | 0 | 0 | -69.90M | -- | 0 | 0 | -927.50M |
| Ending cash balance | 223.60M | 401.30M | 1.68B | 224.70M | 285.20M | 216.80M | 169.90M | 180.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 223.90M | 361.10M | 559.90M | 470.80M | 241.90M | 339.80M |
| Depreciation & amortization | 176.40M | 179.30M | 185.10M | 186.10M | 184.80M | 191.40M |
| Free cash flow | 116.70M | 238.90M | 437.90M | 340.80M | 121.50M | 204.80M |
| Dividends paid | -48.50M | -62.00M | -61.50M | -60.80M | -67.10M | -66.40M |
| Stock buybacks / issuance | 0 | -127.40M | -300.00M | -500.10M | -260.00M | -308.30M |
| Ending cash balance | 195.20M | 189.00M | 189.00M | 180.80M | 183.40M | 170.10M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.54 | -14.03 | 18.10 | 22.04 | 18.46 | 12.84 | 12.95 | 14.05 |
| ROA %i | 4.17 | -5.30 | 5.94 | 7.21 | 6.16 | 4.58 | 5.03 | 5.59 |
| ROIC %i | 6.69 | -5.08 | 9.31 | 10.46 | 8.96 | 7.31 | 7.74 | 8.39 |
| 5-year avg ROE %i | 17.00 | 11.04 | 10.85 | 11.33 | 11.00 | 11.59 | 16.88 | 16.07 |
| EBIT margin %i | 13.48 | -9.16 | 20.03 | 22.23 | 21.72 | 18.22 | 18.30 | 18.23 |
| FCF / sales %i | 10.27 | -- | 12.72 | 17.58 | 2.59 | 9.79 | 14.31 | 18.67 |
| Current ratioi | 1.09 | 0.89 | 1.00 | 0.49 | 0.68 | 0.67 | 0.75 | 0.60 |
| Quick ratioi | 0.84 | 0.69 | 0.93 | 0.42 | 0.57 | 0.56 | 0.62 | 0.51 |
| Debt / assetsi | 36.84 | 42.77 | 45.55 | 47.96 | 50.12 | 46.51 | 42.61 | 42.93 |
| LT debt / equityi | 84.65 | 131.06 | 103.44 | 124.71 | 121.83 | 104.71 | 90.12 | 88.08 |
| Interest coveragei | 4.44 | -2.88 | 5.84 | 7.52 | 6.08 | 3.97 | 4.54 | 5.22 |
| Revenue CAGR (3Y) %i | 8.61 | 3.71 | 7.07 | 13.00 | 13.45 | 8.45 | 4.88 | 5.85 |
| Net income CAGR (3Y) %i | -10.22 | -- | -3.97 | 33.83 | -- | 1.59 | -6.72 | -1.75 |
| FCF CAGR (3Y) %i | -17.46 | -- | -4.24 | 35.20 | -- | -0.60 | -2.08 | 104.52 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.83 | 13.06 | 13.37 | 14.05 | 14.68 | 14.58 |
| ROA %i | 5.08 | 5.32 | 5.45 | 5.59 | 5.87 | 5.79 |
| ROIC %i | 7.72 | 7.93 | 8.12 | 8.39 | 8.68 | 8.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 18.34 | 18.56 | 18.53 | 18.23 | 18.47 | 18.04 |
| FCF / sales %i | 14.11 | 15.70 | 16.82 | 18.67 | 18.13 | 17.15 |
| Current ratioi | 0.85 | 0.77 | 0.74 | 0.60 | 0.61 | 0.60 |
| Quick ratioi | 0.70 | 0.63 | 0.61 | 0.51 | 0.51 | 0.49 |
| Debt / assetsi | 41.87 | 41.10 | 40.68 | 42.93 | 44.45 | 45.63 |
| LT debt / equityi | 86.81 | 79.38 | 82.09 | 88.08 | 89.32 | 92.62 |
| Interest coveragei | 4.73 | 4.97 | 5.15 | 5.22 | 5.39 | 5.24 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Workforce Solutions is the largest reported line at 41.49% of revenue, across 3 reported segments.
- No single line clears half of revenue; U.S. Information Solutions is next at 35.97%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Workforce Solutions41.49%
U.S. Information Solutions35.97%
International22.53%
Quote time 2026-10-08 06:18:57 · For reference only, not investment advice and not tailored to your situation.